News & Updates
Filter by Specialty:
Patients at risk for BE worried over EAC but rarely undergoes screening: study
Patients who are prone to Barrett’s esophagus (BE), specifically those belonging to racial and ethnic minorities, express concern about developing esophageal adenocarcinoma (EAC), reveals a study. However, they seldom go through screening and lack awareness of screening recommendations.
Patients at risk for BE worried over EAC but rarely undergoes screening: study
25 Apr 2023
Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection
Ten-day treatment with vonoprazan 20 mg twice/day plus amoxicillin 750 mg four times/day (VHA-dual) as a first-line therapy for Helicobacter pylori infection results in satisfactory eradication rate of >90 percent, fewer adverse events (AEs), and similar adherence when compared with bismuth quadruple therapy (B-quadruple), results of a study have shown.
Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection
23 Apr 2023
Endoscopic submucosal dissection safer, more cost-effective than transanal endoscopic microsurgery
In patients with early rectal cancer (ERC), endoscopic submucosal dissection (ESD) appears safer and is associated with shorter hospital stay than transanal endoscopic microsurgery (TEM), results of a recent study have shown.
Endoscopic submucosal dissection safer, more cost-effective than transanal endoscopic microsurgery
15 Apr 2023
Excessive air swallowing linked to dyspepsia, poor response to PPI therapy
Swallowing more air appears to induce both dyspepsia and refractoriness to typical symptoms of gastroesophageal reflux disease (GERD) to proton pump inhibitor (PPI) therapy, suggests a study.